Edition:
United Kingdom

Cytosorbents Qtrly Loss Per Share $0.15


Tuesday, 7 May 2019 

May 7 (Reuters) - Cytosorbents Corp ::CYTOSORBENTS REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS AND PROVIDES SECOND QUARTER 2019 GUIDANCE.Q1 REVENUE $5.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF $6.2 MILLION.BELIEVE THAT WE HAVE SUFFICIENT CASH TO FUND OUR OPERATIONS INTO 2020.QTRLY LOSS PER SHARE $0.15.CONTINUE TO FORECAST STRONG REVENUE GROWTH FOR ALL OF 2019, DESPITE A SLOW START IN Q1.Q2 2019 PRODUCT SALES ARE EXPECTED TO RETURN TO OUR HISTORICAL GROWTH TRAJECTORY.CYTOSORBENTS - Q2 PRODUCT SALES ANTICIPATED TO BE HIGHEST QUARTERLY PRODUCT SALES REPORTED IN CO'S HISTORY. 

Company Quote

7.49
 --
19 Jul 2019